Abstract:Inflammation is a double-edged sword for the organism. A proper inflammation response is necessary and beneficial to us in resisting pathogen infection, however, an excessive and continuous inflammation response does harm to the health. In fact, studies over the past decade have strongly linked host inflammatory reaction to the etiology of some chronic diseases. Therefore, “Is inflammation a major cause in all chronic diseases” as one of the 125 scientific questions was proposed by the journal of Science in 2005. Although recent studies have provided direct evidence indicating a key role of chronic inflammation in the initiation and progression of some chronic diseases (such as type 2 diabetes, neurodegenerative diseases, atherosclerosis, gout and cancer), the cellular and molecular mechanisms are not very clear, and the exact therapeutic targets have not been characterized yet. In the recent years, with the in-depth study of the innate immune pattern recognition receptors (PRR) and the mechanism of signal transduction, people found that NLRP3 receptor as well as other PRRs could arouse inflammation reaction and subsequently disease by recognition of the danger signals, which indicated that the PRRs and the related signal pathways may be novel therapeutic targets for the type 2 diabetes and other chronic diseases. Here we summarize the molecular mechanisms of NLRP3 inflammasome activation in response to metabolic danger associated molecular patterns (DAMPs) and discuss the potential therapeutic treatment for type 2 diabetes by targeting to the NLRP3 inflammasome. NLRP3, one of the most-extensively studied NLR sub-family members, has an evolutionarily conserved arrangement of nucleotide binding domain (NBD) for the complex assemble and followed by a leucine rich region (LRR) for the recognition of pattern-associated molecular pattern (PAMP) and damage-associated molecular pattern (DAMP). Two signal pathways are required for the activation of NLRP3 inflammasome. Signal one is provided by the agents of indicated TLRs which aim at inducing nlrp3/IL-1β transcription and subsequent production of pro-IL-1β usually provided by glucose, palmitate, uric acid, or LPS. In order to facilitate processing of pro-IL-1β /18 into their mature forms, signal two is essential to facilitate inflammasome activation and caspase-1-dependent cleavage of pro-IL-1β/18. In addition, NLRP3-dependent activation of caspase-1 also can be triggered by palmitate, ceramide, glucose, uric acid, reactive oxygen species (ROS), and amyloid. Promotion of this cascade occurs in a variety of tissues, including the pancreas, liver, and adipose tissue and may subsequently contribute to tissue dysfunction and the development of insulin resistance. Inhibition of the IL-1R signaling or IL-1β production by the NLRP3-dependent activation of caspase-1 may ward off loss of pancreatic β cell function, yet may also prevent the development of insulin resistance in liver, muscle, and adipose tissue. Although clinical evidence is currently lacking, inhibition of the IL-1R signaling or IL-1β production may avert the development of insulin resistance, which represents an attractive therapeutic target to limit pathological complications associated with obesity, insulin resistance, and type 2 diabetes.

Insulin-Dependent Regulation of mTORC2-Akt-FoxO Suppresses TLR4 Signaling in Human Leukocytes: Relevance to Type 2 Diabetes

Toll-like receptor 4-mediated hyper-responsiveness of gingival epithelial cells to lipopolysaccharide in high-glucose environments.

Periodontitis Contributes to Aberrant Metabolism in Type 2 Diabetes Mellitus Rats by Stimulating the Expression of Adipokines

Insulin-Attenuated Inflammatory Response of Dendritic Cells in Diabetes by Regulating RAGE-PKCβ1-IRS1-NF-κB Signal Pathway: A Study on the Anti-Inflammatory Mechanism of Insulin in Diabetes

Insulin Influences LPS-Induced TNF-α and IL-6 Release Through Distinct Pathways in Mouse Macrophages from Different Compartments

2142-P: Toll-Like Receptors 2 and 4 Act As Brakes to Regulate Adaptive SS-Cell Mass Expansion in Diet-Induced Obesity

Immune Regulation in T1D and T2D: Prospective Role of Foxp3+ Treg Cells in Disease Pathogenesis and Treatment

Insulin Signal Transduction Perturbations in Insulin Resistance

Defects in TLR3 expression and RNase L activation lead to decreased MnSOD expression and insulin resistance in muscle cells of obese people

Mechanisms of Macrophage Polarization in Insulin Signaling and Sensitivity

NLRP3 inflammasome: A novel target for T2DM treatment?

O-GlcNAcylation modulates mTORC1 and autophagy in β-cells, driving diabetes progression

Type-1 interferon induced cross-regulation of IL-10 function: a novel mechanism in type 1 diabetes development

Cellular mechanism of insulin resistance: potential links with inflammation

165-OR: Lipid Signaling in Macrophages Contributes to Inflammatory Transcriptome in Immune Cells

Insulin Resistance is Mechanistically Linked to Hepatic Mitochondrial Remodeling in Nonalcoholic Fatty Liver Disease.

Phosphorylated and O-GlcNAc Modified IRS-1 (Ser1101) and -2 (Ser1149) Contribute to Human Diabetes Type II

TLR9 Deficiency in B Cells Promotes Immune Tolerance via Interleukin-10 in a Type 1 Diabetes Mouse Model

Impaired toll-like receptor signalling in peripheral B cells from newly diagnosed type-2 diabetic subjects

Differential regulation of lipopolysaccharide-induced IL-1β and TNF-α production in macrophages by palmitate via modulating TLR4 downstream signaling

Inhibition of CD226 Co-Stimulation Suppresses Diabetes Development in the NOD Mouse by Augmenting Tregs and Diminishing Effector T Cell Function